ScholarIQanswers from OpenAlex & ORCID
David Fabrizio
ResearcherPublications, citations & collaboration network
David Fabrizio is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David Fabrizio have?
ScholarIQindexed works
David Fabrizio has 202 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David Fabrizio have?
ScholarIQcitation count
David Fabrizio has 16,366 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David Fabrizio?
ScholarIQh-index
David Fabrizio has an h-index of 38 in OpenAlex.
What is the i10-index of David Fabrizio?
ScholarIQi10-index
David Fabrizio has an i10-index of 70 in OpenAlex.
What is the ORCID of David Fabrizio?
ScholarIQorcid
The ORCID for David Fabrizio is on the source record.
What is the OpenAlex record for David Fabrizio?
ScholarIQopenalex
The OpenAlex for David Fabrizio is on the source record.
What are the most-cited papers on David Fabrizio?
ScholarIQmost cited works
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers, Caitlin Connelly, David Fabrizio, Laurie M. Gay, Siraj M. Ali, Riley Ennis, Alexa B. Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki, Franklin W. Huang, Yuting He, James Sun, Uri Tabori, Mark Kennedy, Daniel S. Lieber, Steven Roels, Jared White, Geoffrey A. Otto, Jeffrey S. Ross, Levi A. Garraway, Vincent A. Miller, P. J. Stephens, Garrett M. Frampton
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt, Matthew D. Hellmann, Mark M. Awad, Justin F. Gainor, Alexa B. Schrock, Ryan J. Hartmaier, Sally E. Trabucco, Laurie M. Gay, Siraj M. Ali, Julia A. Elvin, Gaurav Singal, Jeffrey S. Ross, David Fabrizio, Péter M. Szabó, Chang Han, Ariella Sasson, Sujaya Srinivasan, Stefan Kirov, Joseph D. Szustakowski, Patrik Vitazka, Robin Edwards, José A. Bufill, Neelesh Sharma, Sai‐Hong Ignatius Ou, Nir Peled, David R. Spigel, Hira Rizvi, Elizabeth Jiménez Aguilar, Brett W. Carter, Jeremy Erasmus, Darragh Halpenny, Andrew J. Plodkowski, Niamh M. Long, Mizuki Nishino, Warren L. Denning, Ana Galán‐Cobo, Haïfa Hamdi, Taghreed Hirz, Pan Tong, Jing Wang, Jaime Rodriguez‐Canales, Pamela Villalobos, Edwin R. Parra, Neda Kalhor, Lynette M. Sholl, Jennifer L. Sauter, Achim A. Jungbluth, Mari Mino–Kenudson, Roxana Azimi, Yasir Y. Elamin, Jianjun Zhang, Giulia C. Leonardi, Fei Jiang, Kwok‐Kin Wong, J. Jack Lee, Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba, Vincent A. Miller, Garrett M. Frampton, Jedd D. Wolchok, Alice T. Shaw, Pasi A. Jänne, Philip J. Stephens, Charles M. Rudin, William J. Geese, Lee A. Albacker, John V. Heymach
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project
Diana M. Merino, Lisa M. McShane, David Fabrizio, Vincent Funari, Shu‐Jen Chen, James R. White, Paul Wenz, Jonathan Baden, J. Carl Barrett, Ruchi Chaudhary, Li Chen, Wangjuh Chen, Jen‐Hao Cheng, Dinesh Cyanam, Jennifer S. Dickey, Vikas Gupta, Matthew D. Hellmann, Elena Helman, Yali Li, Joerg Maas, Arnaud Papin, Rajesh Patidar, Katie Quinn, Naiyer A. Rizvi, Hongseok Tae, Christine K. Ward, Mingchao Xie, Ahmet Zehir, Chen Zhao, Manfred Dietel, Albrecht Stenzinger, Mark Stewart, Jeff Allen
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
Douglas B. Johnson, Garrett M. Frampton, Matthew J. Rioth, Erik Yusko, Yaomin Xu, Xingyi Guo, Riley Ennis, David Fabrizio, Zachary R. Chalmers, Joel Greenbowe, Siraj M. Ali, Sohail Balasubramanian, James Sun, Yuting He, Dennie T. Frederick, Igor Puzanov, Justin M. Balko, Justin Cates, Jeffrey S. Ross, Catherine Sanders, Harlan Robins, Yu Shyr, Vincent A. Miller, Philip J. Stephens, Ryan J. Sullivan, Jeffrey A. Sosman, Christine M. Lovly
Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
C. Benedikt Westphalen, Matthew Krebs, C. Le Tourneau, Ethan Sokol, Sophia L. Maund, Timothy R. Wilson, Dexter X. Jin, Justin Y. Newberg, David Fabrizio, L. Véronèse, M. Thomas, Filippo de Braud